Integrated Wealth Concepts’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,026
Closed -$616K 849
2021
Q1
$616K Buy
4,026
+118
+3% +$18.3K 0.03% 424
2020
Q4
$611K Buy
3,908
+699
+22% +$89.8K 0.03% 367
2020
Q3
$367K Buy
3,209
+586
+22% +$63.2K 0.02% 409
2020
Q2
$294K Buy
+2,623
New +$278K 0.02% 407
2020
Q1
Sell
-2,367
Closed -$256K 492
2019
Q4
$256K Buy
2,367
+141
+6% +$15.1K 0.02% 399
2019
Q3
$218K Buy
2,226
+457
+26% +$51.5K 0.02% 392
2019
Q2
$232K Buy
1,769
+118
+7% +$15.2K 0.03% 331
2019
Q1
$223K Buy
+1,651
New +$205K 0.04% 296
2018
Q4
Sell
-1,497
Closed -$205K 293
2018
Q3
$205K Buy
+1,497
New +$188K 0.06% 237

Other funds holding ALXN